INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Clinical trial / 2007

In rheumatoid arthritis patients, 12 weeks of glucosamine improved pain and symptom evaluations but showed no effect on conventional antirheumatic measures.

A randomized placebo-controlled trial evaluated daily administration of 1,500 mg glucosamine hydrochloride versus placebo for 12 weeks alongside conventional medication in 51 rheumatoid arthritis patients. Significant improvements were not observed for joint counts, ACR20 responder rates, ESR, or CRP levels. However, the face scale and visual analogue scale for pain significantly favored the glucosamine group, and serum MMP-3 levels decreased. Patient self-evaluations and physician global evaluations showed noticeable symptom improvements, leading authors to conclude that glucosamine seemed to exert some symptomatic effects without conventional antirheumatic effects.

Study type
Randomized placebo-controlled trial
Who was studied
51 rheumatoid arthritis patients (25 in the glucosamine group, 26 in the placebo group)
What was measured
Joint counts, ACR20 responders, face scale, visual analogue scale pain, ESR, CRP, serum MMP-3 levels, patient and physician evaluations

THE PAPER

Effects of glucosamine administration on patients with rheumatoid arthritis.

Nakamura H, Masuko K, Yudoh K, Kato T, Kamada T, Kawahara T. Rheumatol Int, 2007.

PubMed 16953394 ↗DOI 10.1007/s00296-006-0197-1 ↗

Bones & musclesOther health

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.